Briggs Morrison Syndax Pharmaceuticals Inc (SNDX) insider trading activity

SNDX Quotes by TradingView

Briggs Morrison is of Syndax Pharmaceuticals Inc. Currently has a direct ownership of 34,836 shares of SNDX, which is worth approximately $519,753. The most recent transaction as insider was on Jul 01, 2022, when has been sold 62,292 shares (Common Stock) at a price of $19.0 per share, resulting in proceeds of $1,183,548. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.8K
0% 3M change
0% 12M change
Total Value Held $519,753

Briggs Morrison Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2022
SELL
Open market or private sale
$1,183,548 $19.0 p/Share
62,292 Reduced 77.74%
17,836 Common Stock
Jul 01 2022
BUY
Exercise of conversion of derivative security
$448,502 $7.2 p/Share
62,292 Added 43.74%
80,128 Common Stock
Apr 04 2022
SELL
Open market or private sale
$57,211 $18.29 p/Share
3,128 Reduced 14.92%
17,836 Common Stock
Apr 04 2022
BUY
Exercise of conversion of derivative security
$34,095 $10.9 p/Share
3,128 Added 12.98%
20,964 Common Stock
Apr 01 2022
SELL
Open market or private sale
$1,763,235 $17.45 p/Share
101,045 Reduced 85.0%
17,836 Common Stock
Apr 01 2022
BUY
Exercise of conversion of derivative security
$768,940 $10.9 p/Share
70,545 Added 44.39%
88,381 Common Stock
Dec 17 2021
SELL
Open market or private sale
$703,120 $20.0 p/Share
35,156 Reduced 42.11%
48,336 Common Stock
Dec 17 2021
BUY
Exercise of conversion of derivative security
$383,200 $10.9 p/Share
35,156 Added 29.63%
83,492 Common Stock
Sep 20 2021
SELL
Open market or private sale
$1,000 $20.0 p/Share
50 Reduced 0.1%
48,336 Common Stock
Sep 20 2021
BUY
Exercise of conversion of derivative security
$360 $7.2 p/Share
50 Added 0.1%
48,386 Common Stock
Sep 17 2021
SELL
Open market or private sale
$1,410,158 $20.07 p/Share
70,262 Reduced 59.24%
48,336 Common Stock
Sep 17 2021
BUY
Exercise of conversion of derivative security
$505,886 $7.2 p/Share
70,262 Added 37.2%
118,598 Common Stock
Feb 08 2021
SELL
Open market or private sale
$722,456 $20.55 p/Share
35,156 Reduced 42.11%
48,336 Common Stock
Feb 08 2021
BUY
Exercise of conversion of derivative security
$253,123 $7.2 p/Share
35,156 Added 29.63%
83,492 Common Stock
Jan 31 2021
BUY
Other acquisition or disposition
$21,252 $12.0 p/Share
1,771 Added 3.53%
48,336 Common Stock
Nov 10 2020
SELL
Open market or private sale
$350,368 $20.06 p/Share
17,466 Reduced 27.28%
46,565 Common Stock
Nov 10 2020
BUY
Exercise of conversion of derivative security
$125,755 $7.2 p/Share
17,466 Added 21.43%
64,031 Common Stock
Nov 09 2020
SELL
Open market or private sale
$1,261,278 $20.04 p/Share
62,938 Reduced 57.48%
46,565 Common Stock
Nov 09 2020
BUY
Exercise of conversion of derivative security
$453,154 $7.2 p/Share
62,938 Added 36.5%
109,503 Common Stock

Also insider at

CDAK
Codiak BioSciences, Inc. Healthcare
Director
HOWL
Werewolf Therapeutics, Inc. Healthcare
RPTX
Repare Therapeutics Inc. Healthcare
ARVN
ARVINAS, INC. Healthcare
Director
SESN
Sesen Bio, Inc. Healthcare
Director
BM

Briggs Morrison

Waltham, MA

Track Institutional and Insider Activities on SNDX

Follow Syndax Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNDX shares.

Notify only if

Insider Trading

Get notified when an Syndax Pharmaceuticals Inc insider buys or sells SNDX shares.

Notify only if

News

Receive news related to Syndax Pharmaceuticals Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SNDX